US drug advisory recommends Celltrion’s Rituxan biosimilar for approval
기사승인 2018.10.11 12:10:11
Lee Han-soo corea022@docdocdoc.co.kr
- 1PharmaGSK to change HIV treatment paradigm
- 2PharmaHanmi to apply to FDA for approval of new bio drug
- 3Device/ICTAbbott markets new stent for treating coronary artery disease
- 4Hospital24 clinics in Seoul illegally sold, promoted obesity drug Saxenda: police
- 5PharmaDaichi Sankyo, BMS in neck-and-neck competition over blood thinners
- 6Device/ICTPhilips showcases portfolio of innovative solutions at RSNA 2018
- 7PharmaPrescriptions of anticancer drugs spiked this year
set_C1
